You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

BRAF mutant

Showing 1 - 25 of 1,065
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Melanoma (Skin), Skin Cancer, Skin Melanoma Trial in Tampa (Vemurafenib, Cobimetinib)

Recruiting
  • Melanoma (Skin)
  • +3 more
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
Dec 30, 2022

Melanoma Trial in Ottawa, Toronto, Montreal (Vemurafenib, Cobimetinib)

Active, not recruiting
  • Melanoma
  • Ottawa, Ontario, Canada
  • +2 more
Oct 25, 2022

Advanced BRAF Mutant Melanoma Trial in United States (Trametinib 2 mg daily, hydroxychloroquine (HCQ), dabrafenib 150 mg orally

Completed
  • Advanced BRAF Mutant Melanoma
  • Trametinib 2 mg daily
  • +2 more
  • Chicago, Illinois
  • +3 more
Jan 18, 2022

Thyroid Carcinoma Trial in New York (Vemurafenib, serial 124I PET/CT, thyrotropin alpha)

Active, not recruiting
  • Thyroid Carcinoma
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Feb 28, 2022

BRAF V600E Mutation Present, BRAF V600K Mutation Present, Metastatic Malignant Solid Tumor Trial in Boston (Dabrafenib,

Active, not recruiting
  • BRAF V600E Mutation Present
  • +9 more
  • Boston, Massachusetts
  • +1 more
Jun 28, 2022

Melanoma Trial in Pittsburgh (encorafenib, nivolumab, ipilimumab)

Recruiting
  • Melanoma
  • Pittsburgh, Pennsylvania
    UPMC Hillman Cancer Center
Mar 24, 2022

Melanoma Trial in Boston (Trametinib, Dabrafenib, INCB039110)

Active, not recruiting
  • Melanoma
  • Boston, Massachusetts
    Massachusetts General Hospital
Nov 1, 2021

Colorectal Cancer Metastatic Trial (Tunlametinib plus Vemurafenib, Doublets Chemotherapy ± Bevacizumab or Doublets Chemotherapy

Not yet recruiting
  • Colorectal Cancer Metastatic
  • Tunlametinib plus Vemurafenib
  • Doublets Chemotherapy ± Bevacizumab or Doublets Chemotherapy ± Cetuximab
  • (no location specified)
Aug 15, 2023

Melanoma Trial in Sydney, Wollstonecraft, Melbourne (Dabrafenib, Trametinib, Pembrolizumab)

Active, not recruiting
  • Melanoma
  • Sydney, New South Wales, Australia
  • +2 more
Apr 4, 2022

Colorectal Cancer Trial in Hangzhou (Surufatinib, Toripalimab, chemo)

Recruiting
  • Colorectal Cancer
  • Hangzhou, Zhejiang, China
    First affiliated hospital, Zhejiang University
Feb 26, 2022

Melanoma and Metastatic Colorectal Cancer Trial in Worldwide (LGX818)

Active, not recruiting
  • Melanoma and Metastatic Colorectal Cancer
  • Toulouse, Haute-garonne, France
  • +7 more
Dec 2, 2021

Primary Malignant Brain Tumor Trial in China (ABM-1310)

Not yet recruiting
  • Primary Malignant Brain Tumor
  • Beijing, Beijing, China
  • +3 more
May 28, 2023

BRAF NP_004324.2:p.V600M, BRAF V600E Mutation Present, Metastatic Thyroid Gland Carcinoma Trial in Portland (Binimetinib,

Recruiting
  • BRAF NP_004324.2:p.V600M
  • +6 more
  • Portland, Oregon
    Providence Portland Medical Center
Aug 17, 2022

BRAF V600E-mutant Metastatic Non-small Cell Lung Cancer

Recruiting
  • Metastatic Non-small Cell Lung Cancer
  • BRAF V600 Mutation
    • Lyon, Rhône Alpes, France
      CHU Lyon - Hôpital Cardio-Vasculaire et Pneumologique Louis Prad
    Sep 14, 2022

    Advanced Solid Tumor, BRAF V600 Mutation Trial in Nanchang, Jinan, Shanghai (ABM-1310)

    Not yet recruiting
    • Advanced Solid Tumor
    • BRAF V600 Mutation
    • Nanchang, Jiangxi, China
    • +2 more
    Aug 12, 2022

    BRAF V600E Unresectable or Metastatic Melanoma, BRAF V600E Metastatic NSCLC, Melanoma Trial in Guangzhou (Encorafenib)

    Completed
    • BRAF V600E Unresectable or Metastatic Melanoma
    • +2 more
    • Guangzhou, Guangdong, China
      Sun Yat-sen University Cancer Center
    Jun 9, 2022

    Metastatic Melanoma, BRAF Gene Mutation Trial in Lexington (Nilotinib 100mg, Nilotinib 200mg, Nilotinib 300mg)

    Recruiting
    • Metastatic Melanoma
    • BRAF Gene Mutation
    • Nilotinib 100mg
    • +5 more
    • Lexington, Kentucky
      Markey Cancer Center
    Jul 22, 2022

    Metastatic Melanoma, Brain Metastases Trial in Spain (encorafenib, binimetinib, Whole brain radiation therapy)

    Recruiting
    • Metastatic Melanoma
    • Brain Metastases
    • Palma De Mallorca, Baleares, Spain
    • +20 more
    Feb 16, 2022

    Unresectable or Metastatic BRAFV600E Mutant Melanoma Patients

    Recruiting
    • Melanoma (Skin)
    • +2 more
      • Evora, Portugal
        Hospital Evora
      May 30, 2022

      Anaplastic Thyroid Cancer, Thyroid Cancer, BRAF Gene Mutation Trial in United States (Dabrafenib, Trametinib)

      Recruiting
      • Anaplastic Thyroid Cancer
      • +3 more
      • Basking Ridge, New Jersey
      • +6 more
      Jul 1, 2022

      Melanoma, Metastasis Trial in Melbourne (Binimetinib, Encorafenib, Palbociclib)

      Recruiting
      • Melanoma
      • Metastasis
      • Melbourne, Victoria, Australia
        Peter MacCallum Cancer Centre
      Jan 19, 2021

      Colorectal Cancer Metastatic Trial in Guangzhou (Cetuximab, Irinotecan, Vemurafenib)

      Recruiting
      • Colorectal Cancer Metastatic
      • Guangzhou, Guangdong, China
        Sun Yat-sen University Cancer Center
      Mar 7, 2021

      Solid Tumors, Melanoma, NSCLC Trial in France, Spain, United States (CFT1946, Trametinib)

      Recruiting
      • Solid Tumors
      • +4 more
      • Boston, Massachusetts
      • +9 more
      Dec 19, 2022

      Pediatric Recurrent/Refractory BRAFV600E-mutant Gliomas Trial in Canada, United States (Vemurafenib)

      Active, not recruiting
      • Pediatric Recurrent/Refractory BRAFV600E-mutant Gliomas
      • Los Angeles, California
      • +20 more
      Jan 4, 2023

      BRAF V600E Mutation Present, BRAF V600K Mutation Present, Metastatic Melanoma Trial in Boston (drug, biological, other)

      Terminated
      • BRAF V600E Mutation Present
      • +7 more
      • Boston, Massachusetts
      • +1 more
      Mar 9, 2022